- Home
- » Tags
- » Drug discovery
Top View
- Biochemistry Skills for Drug Discovery
- Resistant Depression
- Principles of Drug Design
- Improving Outcomes in Multiple Myeloma with New Treatment Targets
- Aptinyx to Present Preclinical Data for NMDA Receptor Modulators in Neurologic Disorders at Neuroscience 2017
- Molecular Mechanisms of Cereblon-Based Drugs
- Discovery of the Novel Mtor Inhibitor and Its Antitumor Activities in Vitro and in Vivo
- Immunomodulatory Drugs and Their Therapeutic Effect in Hematological Malignancies Through Cereblon
- Chapter 11. the Drug Discovery Process
- Multi-Target Approach for Drug Discovery Against Schizophrenia
- The Role of Pharmacogenomics in Drug
- Pharmacokinetics in Drug Development
- Future Drug Discovery Author Guidelines
- Plants As a Source of Anti-Cancer Agents - G
- Hit and Lead Generation: Beyond High-Throughput Screening
- Biomarkers in Pharmacology and Drug Discovery
- Pharmacodynamics in Pharmacology - Terry Kenakin
- Chapter 10 | Lead Discovery
- Drug Discovery and Development
- Pharmacology Skills for Drug Discovery
- Role of Pharmacogenomics in Drug Discovery and Development A
- Drug Discovery and Evaluation: Methods in Clinical Pharmacology
- Drug Discovery Approaches Targeting the PI3K/Akt Pathway in Cancer
- Biopharmaceutical Research & Development
- Assay Development in Drug Discovery
- New Opportunity for Serotonin Receptor Agonists
- Paclitaxel-Based Chemotherapy Targeting Cancer Stem Cells from Mono- to Combination Therapy
- Pharmacogenomics
- MEDICINAL CHEMISTRY: from HIT to LEAD Alabama Drug Discovery Alliance Lecture Series March 14, 2017 Corinne E
- Drug Discovery and ADMET Process: a Review
- 'Lead' to 'Candidate' Optimisation Using Multi-Parametric Principles
- The Use of Preclinical Pharmacokinetic and Pharmacodynamic Data to Predict Clinical Doses: Current and Future Perspectives Paul Morgan*
- Why, When, and How to Conduct 14C Human Studies
- Pharmacogenomics:Pharmacogenomics 19/4/07 09:51 Page 23
- Drug Discovery and Development - DRDD 1
- ISOA/ARF Drug Development Tutorial
- Pharmacokinetics/ADME in Drug Discovery an Example
- Medications Development: Drug Discovery, Databases, and Computer-Aided Drug Design
- Current Development of Mtor Inhibitors As Anticancer Agents
- Deep Learning in Pharmacogenomics: from Gene Regulation to Patient Stratification Alexandr A
- Utilising Graph Machine Learning Within Drug Discovery and Development
- A Review on Applications of Computational Methods in Drug Screening and Design
- Machine Learning Methods in Drug Discovery
- Marine-Derived Natural Products As ATP-Competitive Mtor Kinase Inhibitors for Cancer Therapeutics
- Aptinyx Announces Publication of Review Article Highlighting
- Chemistry-Driven Hit-To-Lead Optimization Guided by Structure-Based Approaches Laurent Hoffer, Christophe Muller, Philippe Roche, Xavier Morelli
- Pharmacogenomics in Drug Discovery and Development Deepak Gupta* L|E|C|O|M Bradenton School of Pharmacy, Bradenton, FL, USA
- Evotec Reaches Milestone in Integrated Drug Discovery and Development Partnership with Aeovian
- CRBN), a Primary Direct Target of Thalidomide, Using Ferrite Glycidyl Methacrylate (FG) Beads
- HIV Protease Inhibitors for the Treatment of Multiple Myeloma
- 23-1-2017 a Short History of the 5
- Infectious Disease Drug Discovery: Pharmacology Models and in Vitro
- Modeling of 5-Ht2a and 5-Ht2c Receptors and of Their
- Drug Discovery and Drug Development
- Mtor Inhibitors in Cancer Therapy[Version 1; Peer Review: 3
- Targeting the Serotonin 2C Receptor for the Treatment of Obesity and Type
- Drug Discovery Over the Past Thirty Years: Why Aren’T There More New Drugs?